United Kingdom Healthcare & Pharmaceuticals Corporate Bond Yields (USD)
Fitted spot curve as of 2026-07-27
https://bondscovery.com/yield-curve/usd-corporate-healthcare-pharmaceuticals-united-kingdom
United Kingdom Healthcare & Pharmaceuticals Corporate Bond Yields (USD) as of 2026-07-27: 10Y at 5.35%, fitted curve 6M–30Y (4.56%–5.98%), 52 bonds. Live chart, constituents and forward rates on bondScovery.
| Maturity | Fitted yield | Forward rate |
|---|---|---|
| 6M | 4.56% | — |
| 9M | 4.58% | 4.62% |
| 12M | 4.60% | 4.66% |
| 18M | 4.64% | 4.72% |
| 2Y | 4.68% | 4.81% |
| 3Y | 4.77% | 4.94% |
| 4Y | 4.86% | 5.13% |
| 5Y | 4.95% | 5.31% |
| 6Y | 5.04% | 5.48% |
| 7Y | 5.12% | 5.59% |
| 8Y | 5.19% | 5.68% |
| 9Y | 5.26% | 5.85% |
| 10Y | 5.35% | 6.14% |
| 15Y | 5.70% | 6.42% |
| 20Y | 5.87% | 6.37% |
| 25Y | 5.94% | 6.25% |
| 30Y | 5.98% | 6.13% |
2Y, 10Y and the 10Y−2Y spread over time
The 2-year yield is 4.68% and the 10-year 5.35%, a 10Y−2Y spread of +66 bp — positively sloped — as of 2026-07-27. The chart and table below track how they have moved.
Fitted 2Y and 10Y yields and their spread, sampled one build date per month. See all inverted curves today →
| Tenor | Latest2026-07-27 | 1m ago2026-06-26 | 2m ago2026-05-28 | 3m ago2026-04-28 | 4m ago2026-03-30 | 5m ago2026-02-27 | 6m ago2026-01-28 |
|---|---|---|---|---|---|---|---|
| 2Y | 4.68% | 4.36% | 4.39% | 4.19% | 4.31% | 3.81% | 3.93% |
| 10Y | 5.35% | 5.07% | 5.11% | 4.96% | 5.12% | 4.73% | 4.79% |
| 10Y − 2Y | +66 bp | +71 bp | +72 bp | +77 bp | +81 bp | +92 bp | +86 bp |
Bonds in this curve
A selection of 30 of the 56 bonds behind this curve, spread across maturities.
| Issuer | Yield | Maturity | Coupon | ISIN |
|---|---|---|---|---|
| Astrazeneca PLC | 4.62% | 2027-02-26 | 4.80% | US04636NAK90 |
| Glaxosmithkline Capital | 4.54% | 2027-03-12 | 4.32% | US377373AM70 |
| Smith & Nephew PLC | 5.30% | 2027-03-20 | 5.15% | US83192PAC23 |
| CSL Finance PLC | 5.11% | 2027-04-27 | 3.85% | USG2584CAA48 |
| Royalty Pharma PLC | 4.66% | 2027-09-02 | 1.75% | US78081BAJ26 |
| Astrazeneca PLC | 4.60% | 2028-03-03 | 4.88% | US04636NAF06 |
| Glaxosmithkline Capital | 4.41% | 2028-05-15 | 3.88% | US377372AN70 |
| Astrazeneca PLC | 4.60% | 2028-05-28 | 1.75% | US04636NAE31 |
| Astrazeneca PLC | 4.65% | 2029-02-26 | 4.85% | US04636NAL73 |
| CSL Finance PLC | 5.05% | 2029-04-27 | 4.05% | USG2584CAB21 |
| Astrazeneca PLC | 4.77% | 2030-03-03 | 4.90% | US04636NAG88 |
| Glaxosmithkline Capital | 4.72% | 2030-04-15 | 4.50% | US377372AP29 |
| Astrazeneca PLC | 4.84% | 2031-02-26 | 4.90% | US04636NAM56 |
| Astrazeneca PLC | 4.90% | 2031-03-02 | 4.00% | US04636NAQ60 |
| Haleon US Capital LLC | 5.14% | 2032-03-24 | 3.62% | US36264FAM32 |
| CSL Finance PLC | 5.30% | 2032-04-27 | 4.25% | USG2584CAC04 |
| Astrazeneca PLC | 5.00% | 2033-03-03 | 4.88% | US04636NAH61 |
| Astrazeneca PLC | 5.03% | 2033-03-02 | 4.30% | US04636NAR44 |
| Astrazeneca PLC | 5.14% | 2034-02-26 | 5.00% | US04636NAN30 |
| Smith & Nephew PLC | 5.53% | 2034-03-20 | 5.40% | US83192PAD06 |
| Glaxosmithkline Capital | 5.27% | 2035-04-15 | 4.88% | US377372AQ02 |
| Astrazeneca PLC | 5.32% | 2036-03-02 | 4.60% | US04636NAS27 |
| Astrazeneca PLC | 5.44% | 2037-09-15 | 6.45% | US046353AD01 |
| Astrazeneca PLC | 5.69% | 2042-09-18 | 4.00% | US046353AG32 |
| Glaxosmithkline Capital | 5.81% | 2043-03-18 | 4.20% | US377372AJ68 |
| Astrazeneca PLC | 5.74% | 2045-11-16 | 4.38% | US046353AM00 |
| Astrazeneca PLC | 5.77% | 2048-08-17 | 4.38% | US046353AU26 |
| Astrazeneca PLC | 5.73% | 2050-08-06 | 2.12% | US046353AX64 |
| Astrazeneca PLC | 5.73% | 2051-05-28 | 3.00% | US046353AZ13 |
| CSL Finance PLC | 6.09% | 2054-04-03 | 5.42% | US12661PAH29 |